Emerging respiratory viruses

ESPID Education, Albert Osterhaus, 31187

Should influenza be prevented and treated?

ESPID Education, Terho Heikkinen, 31189

How vaccines prevent infections

ESPID Education, Adam Finn, 31185

AN UPDATE ON VACCINES TO PREVENT RESPIRATORY ILLNESSES IN CHILDREN

ESPID Education, Edwards Kathryn, 31186

COULD WE HAVE A UNIFIED EUROPEAN VACCINATION SCHEDULE? - RATIONALE

ESPID Education, Jacek Mrukowicz, 20842

COULD WE HAVE A UNIFIED EUROPEAN VACCINATION SCHEDULE?

ESPID Education, Pier Luigi Lopalco, 20843

CURRENT DIAGNOSIS AND TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN CHILDREN IN THE ERA OF PNEUMOCOCCAL VACCINATION: OLD VERSUS NEW WORLD - EUROPE

ESPID Education, Javier Diez-Domingo, 20844

CURRENT DIAGNOSIS AND TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN CHILDREN IN THE ERA OF PNEUMOCOCCAL VACCINATION: OLD VERSUS NEW WORLD - USA

ESPID Education, Samir S Shah, 20845

BLUE VERSUS RED - RECOMMENDATIONS ACROSS THE OCEAN

ESPID Education, Mike Sharland, 20846

INFANT IMMUNIZATION: STARTING FROM PREGNANCY

ESPID Education, Ener Dinleyici, 20839

ADDRESSING CONCERNS ABOUT VACCINES

ESPID Education, Gary S. Marshall, 20840

HOW PAEDIATRIC INFECTIOUS DISEASE SPECIALISTS MAY ASSIST INTERNISTS TO DEVELOP A LIFETIME VACCINATION SCHEDULE

ESPID Education, Ulrich Heininger, 20841

IMPROVING THE EVIDENCE BASE FOR ANTIBIOTIC USE IN EUROPE - WHAT DO WE DO AND WHY DO WE DO IT

ESPID Education, Nikos Spyridis, 20835

PROPOSED WAYS OF MEASUREMENT OF ANTIBIOTIC CONSUMPTION IN PAEDIATRIC HOSPITALS

ESPID Education, Herman Goossens, 20836

ECDC-PPS OF HEALTHCARE-ASSOCIATED INFECTIONS AND ANTIMICROBIAL USE IN ACUTE CARE HOSPITALS: EXAMPLES OF PAEDIATRIC AND NEONATAL RESULTS

ESPID Education, Carl Suetens, 20837

ANTIMICROBIAL STEWARDSHIP IN PAEDIATRIC HOSPITALS

ESPID Education, Theoklis Zaoutis, 20838

EPIDEMIOLOGY OF RESISTANT GRAM-POSITIVE BACTERIA

ESPID Education, Maria Koliou, 20831

EPIDEMIOLOGY OF RESISTANT AND PAN-RESISTANT GRAM-NEGATIVE BACTERIA

ESPID Education, George L. Daikos, 20832

MANAGEMENT OF INFECTIONS CAUSED BY RESISTANT (RB) AND PAN-RESISTANT BACTERIA (PRB) IN CHILDREN

ESPID Education, Robert Cohen, 20833

PREVENTION OF HORIZONTAL TRANSMISSION OF MICROBES: INFECTION CONTROL ISSUES IN THE HOSPITAL

ESPID Education, Walter Zingg, 20834

PROSPECTS FOR NOVEL TUBERCULOSIS VACCINES: WHERE DO WE STAND?

ESPID Education, Søren Tetens Hoff, 20828

PREVENTION AND TREATMENT OF TUBERCULOSIS IN IMMUNOCOMPROMISED CHILDREN

ESPID Education, Beate Kampmann, 20829

EPIDEMIOLOGY AND MANAGEMENT OF MULTIDRUG-RESISTANT AND EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS IN CHILDREN

ESPID Education, H. Simon Schaaf, 20830

NEWER ANTIBACTERIAL AGENTS FOR GRAM-POSITIVE INFECTIONS

ESPID Education, George Syrogiannopoulos, 20825

ANTIBACTERIAL AGENTS FOR RESISTANT GRAM NEGATIVE INFECTIONS (COLISTIN, TIGECYCLINE, FOSFOMYCIN)

ESPID Education, Charalampos Antachopoulos, 20826

NEW ANTIFUNGAL IN PEDIATRICS

ESPID Education, Adilia Warris, 20827

MICROBIOLOGY OF CYSTIC FIBROSIS

ESPID Education, Niels Hoeiby, 20821

FUNGAL PULMONARY SYNDROMES IN CYSTIC FIBROSIS

ESPID Education, Kris De Boeck, 20822

INHALED VERSUS INTRAVENOUS ANTIBIOTICS: PHARMACOKINETICS/PHARMACODYNAMICS ISSUES

ESPID Education, Roger Brüggemann, 20823

GBS AND THE NEONATE: PREVENTION STRATEGIES

ESPID Education, Pierrette Melin, 20815

LATE-ONSET INFECTIONS IN NICU

ESPID Education, Paul Heath, 20816

PREVENTION OF CANDIDA INFECTIONS IN NEONATES: DIFFERENT VIEWPOINTS - NEONATOLOGY

ESPID Education, Paolo Manzoni, 20817

PREVENTION OF CANDIDA INFECTIONS IN NEONATES: DIFFERENT VIEWPOINTS - MYCOLOGY

ESPID Education, J Peter Donnelly, 20818

LONG-TERM OUTCOMES OF CONGENITAL CYTOMEGALOVIRUS (CMV) INFECTION IN SWEDEN AND THE UNITED KINGDOM

ESPID Education, Claire Townsend, 20819

SCREENING FOR NOSOCOMIAL VIRAL INFECTIONS IN A NEONATAL INTENSIVE CARE UNIT

ESPID Education, Andre Kidszun, 20820

STRENGTHENING EUROPE´S DEFENCES AGAINST INFECTIOUS DISEASES OF THE YOUNG

ESPID Education, Giesecke Johan, 20812

PROTEOMICS AND GENOMICS - CAN THEY HELP US UNDERSTAND THE PATHOGENESIS OF INFECTIOUS DISEASES?

ESPID Education, Mike Levin, 20813

TRANSLATIONAL APPROACHES AND IMPLEMENTATION OF GUIDELINES IN PAEDIATRIC INFECTIOUS DISEASES

ESPID Education, Thomas Walsh, 20814

TUBERCULOSIS: FROM BENCH TO BEDSIDE

ESPID Education, Ben Marais, 8009

PNEUMOCOCCAL VACCINATION STRATEGIES: THE PUBLIC HEALTH PERSPECTIVE

ESPID Education, Kate O'Brien, 8008

Novel insights into the distribution of soil-transmitted helminthiasis and schistosomiasis using real-time PCR diagnosis

ESPID Education, Lisette Van Lieshout, 8007

IL-15 GENE POLYMORPHISMS ARE ASSOCIATED WITH RESISTANCE TO VISCERAL LEISHMANIASIS

ESPID Education, Manoochehr Rasouli, 8006

A NOVEL, FULLY AUTOMATED SAMPLE-TO-RESULT REAL-TIME PCR ASSAY FOR POINT-OF-CARE DETECTION OF DENGUE VIREMIA

ESPID Education, Steven Hatch, 8005

MALARIA AND SALMONELLA CO-INFECTION: A CONFLICT BETWEEN PATHOGEN TOLERANCE AND RESISTANCE

ESPID Education, Aubrey Cunnington, 8004

VISCERAL LEISHMANIASIS

ESPID Education, Shyam Sundar, 8003

CONTROL OF NEGLECTED TROPICAL DISEASES

ESPID Education, David Molyneux, 8002

IMPACT OF THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE ON INVASIVE PNEUMOCOCCAL DISEASE IN ALASKA NATIVE CHILDREN: RESULTS OF A CLINCAL TRIAL

ESPID Education, Rosalyln Singleton, 8086

THE EPIDEMIOLOGY OF INVASIVE MENINGOCOCCAL DISEASE IN EUROPE, 2008 AND 2009

ESPID Education, Ida Czumbel, 8087

PERTUSSIS RISK IN CHILDREN AS A FUNCTION OF TIME SINCE RECEIPT OF THE 5TH DOSE OF ACELLULAR PERTUSSIS VACCINE

ESPID Education, Nicola Klein, 8088

DEFINITION OF A CORRELATE OF PROTECTION FOR INACTIVATED INFLUENZA VACCINES IN CHILDREN LESS THAN FIVE YEARS OF AGE

ESPID Education, Steven Black, 8089

DETECTION OF MYCOPLASMA PNEUMONIAE IN HEALTHY CHILDREN BY REAL TIME PCR-PRELIMINARY DATA FROM THE MYMIC STUDY

ESPID Education, Emiel Spuesens, 8090

DETERMINING THE QUALITY OF CARE FOR ACUTE RESPIRATORY INFECTIONS IN MALAWIAN CHILDREN

ESPID Education, Erica Chapin, 8091

PAEDIATRIC ANTIBIOTIC USE IN THE NETHERLANDS BETWEEN 1996 AND 2010: AN ARPEC STUDY

ESPID Education, Sandra de Bie, 8093

MEASLES AND RUBELLA OUTBREAKS

ESPID Education, Rebecca Martin, 8001

SALMONELLA INFECTIONS IN DEVELOPING COUNTRIES

ESPID Education, Zulfiqar Bhutta, 8000

ANTIVIRAL THERAPY

ESPID Education, Hans L. Zaaijer, 7993

PHARMACOGENOMICS AND ANTIMICROBIAL AGENTS

ESPID Education, Andrew Owen, 7992

CONTINUING INCREASE IN 19A AND 6C SEROTYPE CARRIAGE IN CHILDREN AFTER THE INTRODUCTION OF PCV-7 IN THE NETHERLANDS

ESPID Education, S.M.P.J. Prevaes, 7709

SAFETY OF ADJUVANTED PANDEMIC INFLUENZA VACCINES: BACKGROUND RATE OF NARCOLEPSY IN EUROPE

ESPID Education, Jan Bonhoeffer, 7750

MOLECULAR DIAGNOSIS OF VIRAL INFECTIONS

ESPID Education, Martin Schutten, 7990

NEW DIAGNOSTIC METHODS FOR TUBERCULOSIS

ESPID Education, Nigel Curtis, 7989

MOLECULAR DIAGNOSIS OF INFECTIOUS DISEASES: QUO VADIS?

ESPID Education, Alex Van Belkum, 7988

HOW ACADEMIA AND INDUSTRY CAN CONTRIBUTE TO THE PROMISE OF CURRENT AND NEW VACCINES

ESPID Education, Sian Clayden, 7999

CLEAR AND ALIGNED COMMUNICATION IS VITAL TO REACH THE DESIRED OUTCOMES

ESPID Education, Joanne Yarwood, 7998

WHAT CAN WE LEARN FROM STRATEGIES THAT DO & DON'T WORK?

ESPID Education, Hanna Nohynek, 7997

IMMUNISATION PROGRAMMES: THE GLOBAL PERSPECTIVE

ESPID Education, Pierre Van Damme, 7995

VACCINATION POLICIES: THE EUROPEAN EXPERIENCE

ESPID Education, Kari Johansen, 7994

HIV/AIDS IN CHILDREN

ESPID Education, Diana Gibb, 7987

FROM IMMUNODEFICIENCIES TO INFECTIOUS DISEASES

ESPID Education, Alain Fischer, 7986

INHIBITING THE HOST FOR KILLING INTRACELLULAR PATHOGENS

ESPID Education, Jacques Neefjes, 7985

THE PARADOX OF GLOBAL HEALTH: SUCCESS, YET CRISIS

ESPID Education, Richard Horton, 7984

CAN WE LEARN FROM MOTHER TO CHILD TRANSMISSION OF HIV-1 FOR THE MILLENIUM DEVELOPMENT GOAL 4 AND BEYOND?

ESPID Education, Francoise Barre-Sinoussi, 7982

SEVERE STREPTOCOCCAL GROUP A DISEASE IN CHILDREN WITH OR WITHOUT RISK FACTORS OF INVASIVE INFECTION: CLINICAL FEATURES AND EMM-TYPES DISTRIBUTION.

ESPID Education, Sophie Dugué, 7680

INVASIVE GROUP A STREPTOCOCCAL INFECTIONS IN THE VARICELLA VACCINE ERA.

ESPID Education, Julie Frere, 7681

HOSPITALIZATION DUE TO VARICELLA IN THE NETHERLANDS

ESPID Education, Hester de Melker, 7682

MOLECULAR AND CLINICAL CHARACTERIZATION OF ROTAVIRUS FROM DIARRHEAL INFANTS ADMITTED TO PEDIATRIC EMERGENY UNITS IN FRANCE, 2006-2010.

ESPID Education, Alexis de ROUGEMONT, 7683

VIRAL CO-INFECTIONS IN INFANTS WITH COMMUNITY-ACQUIRED PNEUMONIA (CAP)

ESPID Education, Susanna Esposito, 7685

VARIATION IN A SURFACE-EXPOSED REGION OF THE MYCOPLASMA PNEUMONIAE P40 PROTEIN AS A CONSEQUENCE OF DNA RECOMBINATION BETWEEN REPMP5 ELEMENTS

ESPID Education, Emiel Spuesens, 7686

EVOLUTION OF THE MENINGOCOCCAL DISEASE´S INCIDENCE ON PAEDIATRIC NAVARRE´S POPULATION (NORTH OF SPAIN)

ESPID Education, Enrique Bernaola Iturbe, 7704

IMMUNOGENICITY AND PROTECTIVITY OF STAPHYLOCOCCUS AUREUS AND STREPTOCOCCUS PNEUMONIAE PROTEINS IN RELATION TO NASOPHARYNGEAL COLONIZATION AND VACCINATION

ESPID Education, S.M.P.J. Prevaes, 7705

NATURAL ANTIBODIES AGAINST SEVERAL PNEUMOCOCCAL VIRULENCE PROTEINS IN CHILDREN IN THE PRE-PNEUMOCOCCAL VACCINE-ERA: THE GENERATION R STUDY.

ESPID Education, Ankie Lebon, 7707

IMPACT OF THE 13-VALENT PNEUMOCOCCAL VACCINE ON THE INCIDENCE OF PAEDIATRIC EMPYEMA IN THE NORTH OF ENGLAND

ESPID Education, Mohamed Elemraid, 7708

KINGELLA AS A CAUSE OF SEPTIC ARTHRITIS IN CHILDREN: THE BENEFIT OF MOLECULAR TECHNIQUES FOR MICROBIOLOGICAL DIAGNOSIS

ESPID Education, Jesus Saavedra-Lozano, 7724

IMPACT OF GEN-PROBE'S AMPLIFIED MYCOBACTERIUM TUBERCULOSIS DIRECT TEST ON TUBERCULOSIS DIAGNOSIS IN CHILDREN

ESPID Education, Garyfallia Syridou, 7725

QUANTIFERON®-TB GOLD IN-TUBE PERFORMANCE FOR TUBERCULOSIS DIAGNOSIS IN 0-5 YEARS OF AGE CHILDREN

ESPID Education, Agathe de Lauzanne, 7726

IDENTIFICATION OF SERUM BIOMARKERS OF PAEDIATRIC TUBERCULOSIS USING SELDI

ESPID Education, Shea Hamilton, 7727

VALUE OF MOLECULAR DIAGNOSTIC TOOLS IN VIRAL RESPIRATORY ILLNESS IN HOSPITALIZED CHILDREN

ESPID Education, Janette Rahamat-Langendoen, 7728

CLINICAL CHARACTERISTICS OF SWINE FLU (H1N1) COMPARED TO OTHER RESPIRATORY VIRUSES IN THE UNITED KINGDOM

ESPID Education, Jesal Patel, 7746

DOSE-RANGING PAEDIATRIC STUDY: IDENTIFICATION OF A NOVEL MF59-ADJUVANTED 2A2B QUADRIVALENT INFLUENZA VACCINE

ESPID Education, Timo Vesikari, 7747

MF59®-ADJUVANTED H1N1 VACCINES IN CHILDREN 3-17 YEARS: SAFETY AND IMMUNOGENICITY FOLLOWING A 1-YEAR BOOSTER VACCINATION

ESPID Education, Maria Lattanzi, 7748

PERTUSSIS AFTER END OF A MASS VACCINATION PROJECT - END OF THE VACCINATION HONEY- MOON

ESPID Education, Birger Trollfors, 7767

'DECLINE OF IgG-PERTUSSIS TOXIN IN UMBILICAL CORD BLOOD AND NEONATAL SERUM'

ESPID Education, N.A. van Welie, 7768

THE B-CELL RESPONSE TO PRIMARY AND BOOSTER DOSES OF MENACWY‑CRM VACCINE ADMINISTERED AT 2, 4 AND 12 MONTHS OF AGE

ESPID Education, Geraldine Blanchard-Rohner, 7769

MAINTENNANCE OF IMMUNE RESPONSE THROUGHOUT CHILDHOOD FOLLOWING SEROGROUP C MENINGOCOCCAL CONJUGATE VACCINATION IN EARLY CHILDHOOD

ESPID Education, Ameneh Khatami, 7771

SYNCOPE IN MASS VACCINATION CAMPAIGNS IN THE NETHERLANDS; MENC IN 2002, HPV IN 2009, H1N1 IN 2009

ESPID Education, Patricia Vermeer-de Bondt, 7777

EFFECTS OF SIMPLIFICATION OF HAART IN HIV INFECTED CHILDREN

ESPID Education, Mar Santos-Sebastián, 7792

13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV13) IN CHILDREN PREVIOUSLY PARTIALLY IMMUNIZED WITH 7-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV7): PHASE 3, OPEN-LABEL TRIAL

ESPID Education, Sven-Arne Silfverdal, 7793

HIGHER STAPHYLOCOCCUS AUREUS COLONIZATION IN 11-MONTH-OLD CHILDREN FOLLOWING PCV-7 VACCINATIONS IN INFANCY

ESPID Education, S.M.P.J. Prevaes, 7794

LIMITED IMPACT OF THE 7-VALENT PNEUMOCOCCAL VACCINE ON PAEDIATRIC EMPYEMA IN THE NORTH OF ENGLAND

ESPID Education, Mohamed Elemraid, 7795

DEVELOPMENT OF A RAPID METHOD FOR IDENTIFICATION AND QUANTITATION OF PNEUMOCOCCAL CAPSULAR POLYSACCHARIDES

ESPID Education, Manoj Kumar, 7797